Skip to main content

The Use of Ketorolac Tromethamine Oral Rinse for the Treatment of Periodontitis in Adults

  • Chapter
Side Effects of Anti-Inflammatory Drugs IV
  • 145 Accesses

Abstract

Periodontitis is a chronic infectious and inflammatory disease which afflicts approximately three quarters of the world’s adult population over the age of thirty-five. Recently published studies have demonstrated that long-term administration (≥6 months) of non-steroidal anti-inflammatory drugs (NSAIDs) can halt the progressive loss of alveolar bone associated with this disease. The safe and efficacious twice daily use for six months of 0.1% ketorolac tromethamine oral rinse for the prevention of periodontal disease progression in adults has recently been demonstrated. This presentation summarizes our results to date regarding the pharmacokinetics, pharmacodynamics, safety and efficacy of the topical oral rinse form of this potent NSAID in patients with periodontitis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Williams RC. Periodontal disease. N Engl J Med. 1990;322:373–82.

    Article  PubMed  CAS  Google Scholar 

  2. Page R. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodont Res. 1991;26:230–42.

    Article  PubMed  CAS  Google Scholar 

  3. Offenbacher S, Heasman PA, Collins JG. Modulation of host PGE2 secretion as a determinant of periodontal disease expression. J Periodont. 1993;64:432–44.

    PubMed  CAS  Google Scholar 

  4. Offenbacher S, Odle BM, van Dyke TE. The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J Periodont Res. 1986;21:101–12.

    Article  PubMed  CAS  Google Scholar 

  5. Cavanaugh PF Jr, McDonald JS, Pavelic L, Limardi RI, Gluckman JL, Pavelic ZP. Immunohistochemical localization of prostaglandin H synthase isoenzyme proteins in the gingival tissue of patients with periodontitis. Inflammopharmacology. 1995;3:109–19.

    Article  Google Scholar 

  6. Allison AC, Chin RC, Cheng Y. Cyclooxygenase inhibitors vary widely in potency for preventing cytokine-induced bone resorption. Ann NY Acad Sci. 1993;696:303–6.

    Article  PubMed  CAS  Google Scholar 

  7. Jeffcoat MK, Williams RC, Reddy MS, English R, Goldhaber P. Flurbiprofen treatment of human periodontitis: effect on alveolar bone height and metabolism. J Periodont Res. 1988;23:381–5

    Article  PubMed  CAS  Google Scholar 

  8. Jeffcoat MK, Page R, Reddy M et al. Use of digital radiography to demonstrate the potential of naproxen as an adjunct in the treatment of rapidly progressive periodontitis. J Periodont Res. 1991;26:415–21.

    Article  PubMed  CAS  Google Scholar 

  9. Reddy MS, Palcanis KG, Barnett ML, Haigh S, Charles CH, Jeffcoat MK. Efficacy of meclofenamate sodium (MECLOMEN) in the treatment of rapidly progressive periodontitis. J Clin Periodontal. 1993;20:635–40.

    Article  CAS  Google Scholar 

  10. Rooks WH, Maloney PJ, Shott LD et al. The analgesic and anti-inflammatory profile of ketorolac and its tromethamine salt. Prog Exp Clin Res. 1985;11:479–92.

    CAS  Google Scholar 

  11. Gu L, Strickley RG. Preformulation salt selection. Physical property comparisons of the tris(hydroxymethyl)aminomethane (THAM) salts of four analgesic/antiinflammatory agents with the sodium salts and the free acids. Pharm Res. 1987;4:255–7.

    Article  PubMed  CAS  Google Scholar 

  12. Kelm GR, Bruns AE, Deibel RM, Kinnett GO, Penafiel JV, Buchanan W. Gingival absorption of ketorolac in the dog. Pharm Res. 1994;11(10 Suppl):S259.

    Google Scholar 

  13. Jung D, Mroszczak EJ, Bynum L. Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular, and oral administration. Eur J Clin Pharmacol. 1988;35:423–5.

    Article  PubMed  CAS  Google Scholar 

  14. Doyle MJ, Buchanan W, Kelm GR et al. Inhibition of PGE2 with ketorolac rinses. J Dent Res. 1994;73:(SI-AADR Abstracts)No. 125.

    Google Scholar 

  15. Jeffcoat MK, Reddy MS, Haigh S et al. A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis. J Periodont. 1995;66:329–38.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Cavanaugh, P.F. (1997). The Use of Ketorolac Tromethamine Oral Rinse for the Treatment of Periodontitis in Adults. In: Rainsford, K.D. (eds) Side Effects of Anti-Inflammatory Drugs IV. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5394-2_33

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-5394-2_33

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6269-5

  • Online ISBN: 978-94-011-5394-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics